This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Dyax Corp
DYAX : NASDAQ : Health Care
$8.93 -0.11 | -1.22%
Today's Range: 8.71 - 9.09
Avg. Daily Volume: 1,281,600
07/25/14 - 4:00 PM ET

PEER GROUP: Biotechnology



Ticker Company Name Recent
Price($)
Market
Cap($M)
Price/
Earnings
Net Sales
TTM($M)
Net Income
TTM($M)
DYAX DYAX CORP 8.14 1105.42 n/m 56.00 1.45
PDLI PDL BIOPHARMA INC 9.20 1477.47 5.08 490.74 26.14
EXAS EXACT SCIENCES CORP 16.34 1353.65 n/m 3.40 -17.91
KERX KERYX BIOPHARMACEUTICALS INC 13.62 1245.59 n/m 10.00 42.85
CLVS CLOVIS ONCOLOGY INC 36.44 1235.75 n/m 13.63 n/a
ACOR ACORDA THERAPEUTICS INC 29.38 1226.12 66.77 345.08 12.61
CBPO CHINA BIOLOGIC PRODUCTS INC 45.00 1089.86 21.33 205.59 7.29
HALO HALOZYME THERAPEUTICS INC 8.67 1079.49 n/m 54.93 17.57
CLDX CELLDEX THERAPEUTICS INC 12.05 1076.76 n/m 2.11 -81.11
ARNA ARENA PHARMACEUTICALS INC 4.81 1056.52 n/m 85.84 209.08
LGND LIGAND PHARMACEUTICAL INC 50.66 1049.93 n/a 54.30 31.66
The peer group comparison is based on Major Biotechnology companies of comparable size.

Price Earnings Comparison

DYAX Ind Avg S&P 500
n/m 52.05 19.42
 

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV

Latest Stock Upgrades/Downgrades

Brokerage Partners


Top Rated Stocks Top Rated Funds Top Rated ETFs